Skip to content

FDA, Generics Industry Agree on Inspection Fees

August 15, 2011

According to reports in the New York Times and on FiercePharma, the FDA and the generic pharmaceutical industry has reach agreement on annual user fees of just under $300 million to cover inspections of foreign manufacturing plants every 2 years. It is being predicted that Congress will give its approval to this agreement.

For more details see

Comments are closed.